Community Health Begins with Source Water
EQO is the only company capable of offering eRNA diagnostic solutions through the use of an automated collection system. EQO Dx CALYPSO autonomous samplers are installed to collect and preserve biological material and identify targeted live organisms of interest at the single molecule level.
EQO scientist extract, preserve, catalogue, and analyze genetic information to determine the stage of infestation. EQO then provides the customer with actionable information needed to efficiently treat a population of zebra mussels, whether it's a newly established population or an older infestation.
EQO automated collection system can be semi-permanently installed onsite to monitor population activity. Effective management of invasive species infestation requires population activity information. This can only be determined through consistent monitoring, allowing for treatment optimization and quality control.
EQO is developing a biotherapeutic infestation treatment funded by the National Science Foundation and the U.S. Bureau of Reclamation.
The product will have limited to
no off-target effects with high efficiency. For more information, please contact us.
EQO is the leading the way in diagnostic and treatment
of invasive species in aquatic ecosystems.
EQO offers invasive species prevention, mitigation, and monitoring through EQO Dx;
and is developing EQO Rx, an eradication solution.
EQO Dx: Invasive population analytics powered by RNA.
EQO is the only company capable of offering eRNA solutions, providing the necessary metrics for scalable prevention and mitigation.
EQO offers scalable automated collection and preservation of biological samples for targeted and highly sensitive eDNA and eRNA analytics.
EQO Rx: The prescription for restoration.
Environmentally friendly, biotherapeutic, eradication solution being developed with the support of the National Science Foundation and Bureau of Reclamation for the control of invasive mussels.
Biomolecule packaged in an attenuated, not live, microalgae delivery vector.
Based on previous research in the field of oncology which has seen clinical efficacy for the treatment of cancer without harm to non-tumor cells.